Patent assignee · US · COMPANY

TP Therapeutics, Inc.

4Patents
4Active
4Granted
48Portfolio score

Filing activity: Jan 23, 2015 → May 31, 2017

Most-cited patents

PatentTitleAreaCited byStatus
US9714258B2 Diaryl macrocycles as modulators of protein kinases Chemistry; Metallurgy 21 Active
US10294242B2 Diaryl macrocycle polymorph Emerging Cross-Sectional Technologies 16 Active
US10246466B2 Diaryl macrocycles as modulators of protein kinases Chemistry; Metallurgy 16 Active
US10316044B2 Chiral diaryl macrocycles as modulators of protein kinases Chemistry; Metallurgy 16 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.